- Home
- MIRA vs CHNR Comparison
MIRA vs CHNR Comparison
Compare MIRA & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- CHNR
- Stock Information
- Founded
- MIRA 2020
- CHNR N/A
- Country
- MIRA United States
- CHNR Hong Kong
- Employees
- MIRA N/A
- CHNR N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- MIRA Health Care
- CHNR Basic Materials
- Exchange
- MIRA Nasdaq
- CHNR Nasdaq
- Market Cap
- MIRA 17.1M
- CHNR 6.4M
- IPO Year
- MIRA 2023
- CHNR 1995
- Fundamental
- Price
- MIRA $1.05
- CHNR $0.76
- Analyst Decision
- MIRA Strong Buy
- CHNR
- Analyst Count
- MIRA 2
- CHNR 0
- Target Price
- MIRA $14.00
- CHNR N/A
- AVG Volume (30 Days)
- MIRA 552.1K
- CHNR 148.5K
- Earning Date
- MIRA 11-11-2024
- CHNR 01-01-0001
- Dividend Yield
- MIRA N/A
- CHNR N/A
- EPS Growth
- MIRA N/A
- CHNR N/A
- EPS
- MIRA N/A
- CHNR N/A
- Revenue
- MIRA N/A
- CHNR N/A
- Revenue This Year
- MIRA N/A
- CHNR N/A
- Revenue Next Year
- MIRA N/A
- CHNR N/A
- P/E Ratio
- MIRA N/A
- CHNR N/A
- Revenue Growth
- MIRA N/A
- CHNR N/A
- 52 Week Low
- MIRA $0.51
- CHNR $0.55
- 52 Week High
- MIRA $6.40
- CHNR $8.85
- Technical
- Relative Strength Index (RSI)
- MIRA 38.97
- CHNR 53.35
- Support Level
- MIRA $1.04
- CHNR $0.68
- Resistance Level
- MIRA $1.20
- CHNR $0.83
- Average True Range (ATR)
- MIRA 0.07
- CHNR 0.10
- MACD
- MIRA 0.02
- CHNR -0.00
- Stochastic Oscillator
- MIRA 19.44
- CHNR 24.60
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.